Elotuzumab in combination with pomalidomide and dexamethasone for the treatment of multiple myeloma

Eleutherakis-Papaiakovou, E; Gavriatopoulou, M; Ntanasis-Stathopoulos, I; Kastritis, E; Terpos, E; Dimopoulos, MA

Dimopoulos, MA (reprint author), Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece.

EXPERT REVIEW OF ANTICANCER THERAPY, 2019; 19 (11): 921

Abstract

Introduction: Despite major advances in the therapeutic management of multiple myeloma (MM), it remains an incurable disease. Several combinations of ......

Full Text Link